Submission of Audited Standalone and Consolidated Financial Results for Quarter and Financial Year ended March 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Yash Chemex Limited's board approved audited standalone and consolidated financial results for Q4 FY25 and the full year ended March 31, 2025, along with an unmodified audit opinion from statutory auditor M/s S. L. Patel & Co. On a standalone basis, profit before tax surged sharply to Rs. 197.34 lakhs versus just Rs. 1.05 lakhs in FY24, while operating cash flow jumped to Rs. 303.52 lakhs from Rs. 38.03 lakhs. Standalone total assets rose to Rs. 4,130.72 lakhs (vs Rs. 4,029.13 lakhs) and total equity improved to Rs. 2,489.56 lakhs. On a consolidated basis, total assets grew to Rs. 8,510.81 lakhs (from Rs. 7,725.45 lakhs) with total equity at Rs. 5,739.01 lakhs, reflecting contribution from subsidiary Yasons Chemex Care Limited. The board also appointed M/s N. H. Desai & Co. as internal auditor for FY26 and adopted an amended Code of Fair Disclosure of UPSI.
Sharp rebound in standalone profits and improved operating cash flow signal a strong financial recovery, which is positive for shareholders. However, investors should note the change in statutory auditor (from H S K & Co. LLP to S. L. Patel & Co.) and ongoing consolidated operating cash burn that warrants monitoring.